Regarding the risk stratification, the patient status (age, degree and duration of neutropenia, colonizing microbial flora, CVC), the therapeutic approach (dose intense and time of chemotherapy) and the characteristics of the episode (fever, blood pressure, CRP) are of major concern. This evidence concerns the gene CRP and neutropenia.